Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report
U Beller, A Chachoua, JL Speyer, J Sorich, M Dugan, L Liebes, R Hayes, EM BeckmanVolume:
31
Year:
1990
Language:
english
DOI:
10.1016/0020-7292(90)90929-f
File:
PDF, 266 KB
english, 1990